Ranganathan R - Search Results

1

Adoptive T cell therapy: Boosting the immune system to fight cancer.

Leon E, Ranganathan R, Savoldo B. Leon E, et al. Among authors: ranganathan r. Semin Immunol. 2020 Jun;49:101437. doi: 10.1016/j.smim.2020.101437. Epub 2020 Nov 29. Semin Immunol. 2020. PMID: 33262066 Free PMC article. Review.

2

CAR T cells Targeting Human Immunoglobulin Light Chains Eradicate Mature B-cell Malignancies While Sparing a Subset of Normal B Cells.

Ranganathan R, Shou P, Ahn S, Sun C, West J, Savoldo B, Dotti G. Ranganathan R, et al. Clin Cancer Res. 2021 Nov 1;27(21):5951-5960. doi: 10.1158/1078-0432.CCR-20-2754. Epub 2021 Apr 15. Clin Cancer Res. 2021. PMID: 33858858 Free PMC article.

3

Cellular kinetics: A clinical and computational review of CAR-T cell pharmacology.

Qi T, McGrath K, Ranganathan R, Dotti G, Cao Y. Qi T, et al. Among authors: ranganathan r. Adv Drug Deliv Rev. 2022 Sep;188:114421. doi: 10.1016/j.addr.2022.114421. Epub 2022 Jul 6. Adv Drug Deliv Rev. 2022. PMID: 35809868 Free PMC article. Review.

4

Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors.

Moon EK, Wang LC, Dolfi DV, Wilson CB, Ranganathan R, Sun J, Kapoor V, Scholler J, Puré E, Milone MC, June CH, Riley JL, Wherry EJ, Albelda SM. Moon EK, et al. Among authors: ranganathan r. Clin Cancer Res. 2014 Aug 15;20(16):4262-73. doi: 10.1158/1078-0432.CCR-13-2627. Epub 2014 Jun 11. Clin Cancer Res. 2014. PMID: 24919573 Free PMC article.

5

Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer.

Moon EK, Ranganathan R, Eruslanov E, Kim S, Newick K, O'Brien S, Lo A, Liu X, Zhao Y, Albelda SM. Moon EK, et al. Among authors: ranganathan r. Clin Cancer Res. 2016 Jan 15;22(2):436-47. doi: 10.1158/1078-0432.CCR-15-1070. Epub 2015 Aug 31. Clin Cancer Res. 2016. PMID: 26324743 Free PMC article.

6

Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphoma.

Walburn T, Grover NS, Shen CJ, Ranganathan R, Dittus C, Beaven AW, Wang AZ, Wang K. Walburn T, et al. Among authors: ranganathan r. Leuk Lymphoma. 2021 Jan;62(1):68-75. doi: 10.1080/10428194.2020.1821014. Epub 2020 Sep 16. Leuk Lymphoma. 2021. PMID: 32935601

7

A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors.

Liu X, Ranganathan R, Jiang S, Fang C, Sun J, Kim S, Newick K, Lo A, June CH, Zhao Y, Moon EK. Liu X, et al. Among authors: ranganathan r. Cancer Res. 2016 Mar 15;76(6):1578-90. doi: 10.1158/0008-5472.CAN-15-2524. Cancer Res. 2016. PMID: 26979791 Free PMC article.

8

The Limitations and Promise of Immunotherapy With Chimeric Antigen-Modified T Cells.

Ranganathan R, Foster MC. Ranganathan R, et al. Oncology (Williston Park). 2016 Oct 15;30(10):889-90. Oncology (Williston Park). 2016. PMID: 27744646 No abstract available.

9

Natural Language Prompts Guide the Design of Novel Functional Protein Sequences.

Praljak N, Yeh H, Moore M, Socolich M, Ranganathan R, Ferguson AL. Praljak N, et al. Among authors: ranganathan r. bioRxiv [Preprint]. 2024 Nov 11:2024.11.11.622734. doi: 10.1101/2024.11.11.622734. bioRxiv. 2024. PMID: 39605414 Free PMC article. Preprint.

10

Rest the brain to learn new gait patterns after stroke.

Krishnan C, Augenstein TE, Claflin ES, Hemsley CR, Washabaugh EP, Ranganathan R. Krishnan C, et al. Among authors: ranganathan r. J Neuroeng Rehabil. 2024 Oct 29;21(1):192. doi: 10.1186/s12984-024-01494-8. J Neuroeng Rehabil. 2024. PMID: 39472911 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters